In conclusion, we showed the clinically relevant classification of endometrial carcinoma when the analysis of MMR and p53 protein expression was combined with the assessment of tumor-infiltrating CD8-positive TCs, inspired by the concepts of TCGA. The gene discussed is CD8A; the disease is endometrial carcinoma.